MedPath

Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer

Recruiting
Conditions
Head and Neck Cancer
Registration Number
NCT00230308
Lead Sponsor
Stanford University
Brief Summary

Through this study, we hope to learn more about the mechanisms, which may contribute to development and progression of head and neck cancer. The long-term goal of this study will be to develop new strategies and drugs for the diagnosis and treatment of head and neck cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria

All patients undergoing surgery at Stanford University for head and neck cancer.

Exclusion Criteria

Non-Stanford patients.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University School of Medicine

🇺🇸

Stanford, California, United States

Stanford University School of Medicine
🇺🇸Stanford, California, United States
Nikita Bedi
Contact
650-723-5957
nbedi@stanford.edu
Cancer Clinical Trials Office
Contact
(650) 498-7061
Quynh-Thu Le
Sub Investigator
Willard E Fee Jr
Sub Investigator
Zijie Sun
Sub Investigator
Jan Matthijs van de Rijn
Sub Investigator
Dr Michael Kaplan
Sub Investigator
John B Sunwoo
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.